Therapeutic plasma exchange for urgent rivaroxaban reversal

Keyphrases

• Anti-factor Xa 20%
• Anti-Xa Activity 20%
• Anticoagulation 20%
• Atrial Fibrillation 20%
• Bleeding 20%
• Bleeding Risk 20%
• Cold Ischemic Time 20%
• Commercially Available 20%
• Deceased Donor Kidneys 20%
• Direct Oral Anticoagulants 20%
• Donor Kidney 20%
• End-stage Renal Disease 20%
• Factor Xa Inhibitors 20%
• Kidney Disease 20%
• Kidney Transplant Recipients 20%
• Kidney Transplantation 20%
• Large Volume 20%
• Life-threatening 20%
• Liver Dysfunction 20%
• Older Men 20%
• Oral Anticoagulants 20%
• Paroxysmal Atrial Fibrillation 20%
• Patient Plasma 20%
• Rivaroxaban 100%
• Stroke Prevention 20%
• Therapeutic Plasma Exchange 100%
• Urgent Surgery 20%
• Vitamin K Antagonists 20%

Medicine and Dentistry

• Anticoagulation 20%
• Antithrombotic 20%
• Apoplexy 20%
• Atrial Fibrillation 20%
• Bleeding 20%
• Blood Clotting Factor 10a Inhibitor 20%
• Direct Oral Anticoagulant 20%
• End Stage Renal Disease 20%
• Heart Muscle Ischemia 20%
• Kidney Dysfunction 20%
• Kidney Graft 20%
• Kidney Transplantation 20%
• Liver Dysfunction 20%
• Paroxysmal Atrial Fibrillation 20%
• Plasma Exchange 100%
• Prothrombinase 20%
• Rebound 20%
• Rivaroxaban 100%
• Vitamin K Antagonist 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Anticoagulant Agent 20%
• Antivitamin K 20%
• Atrial Fibrillation 20%
• Bleeding 20%
• Blood Clotting Factor 10a 20%
• Blood Clotting Factor 10a Inhibitor 20%
• Cerebrovascular Accident 20%
• Direct Oral Anticoagulant 20%
• End Stage Renal Disease 20%
• Heart Muscle Ischemia 20%
• Kidney Dysfunction 20%
• Liver Dysfunction 20%
• Paroxysmal Atrial Fibrillation 20%
• Rivaroxaban 100%